Using TMS to Increase Executive Function in Older Adults
NCT ID: NCT02767323
Last Updated: 2021-04-05
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
184 participants
INTERVENTIONAL
2016-08-15
2020-03-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Here, the investigator proposes to use fMRI-guided rTMS to enhance working memory performance. This will be achieved through three Aims. In the first, registered on this record, the investigator will stimulate both old and young healthy adults while they perform the WM task that will engage the frontoparietal network. To define the optimal rTMS target, rTMS will be applied over the dorsolateral prefrontal cortex (DLPFC: Aim 1a); or over the parietal cortex (PC: Aim 1b). These regions are involved not only in the maintenance of items in WM, but also in their manipulation, therefore applying rTMS over these areas should create WM performance enhancements that will be long-lasting. In Aim 1c, a direct within-subject comparison of these 2 targeted sites is performed.
In the second and third Aims, older adults will receive active or sham rTMS over the optimal target (defined in Arm 1) during two weeks of daily sessions while they perform the WM tasks. In the second Aim, the investigator hopes to demonstrate that the cumulative effect of multiple TMS sessions, in tandem with the synergistic effects of simultaneous TMS + WM training, create WM performance enhancements greater than those found with WM training alone, whose effects are long-lasting, continuing a month following the course of TMS sessions. In the third, the investigator will investigate whether the WM enhancements generated by the two weeks of TMS sessions will generalize to other cognitive tasks. The success of these 3 Aims will provide proof in principle for long-lasting, transferable effects of TMS in remediating WM and more general cognitive deficits due to aging, and point to a possible non-invasive brain stimulation therapy for cognitive decline in healthy aging and in dementia. This record is a reflection of Aim1, Aim 2 and 3 will be registered separately.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Network-guided TMS in Early Alzheimer's Disease
NCT04549155
TMS in Preclinical and Prodromal AD: Modulation of Brain Networks and Memory
NCT04294888
Effects of rTMS on Human Brain Activity
NCT04242810
TMS Modulation of Insula-related Brain Networks
NCT02689323
Repetitive Transcranial Magnetic Stimulation for Dementia
NCT02621424
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active or Sham rTMS over the DLPFC (Aim1a)
excitatory rTMS applied over the DLPFC (fMRI-guided). Active and Sham rTMS will be tested in a within subject design
rTMS
excitatory 5Hz rTMS will be used
Sham rTMS
an electrical sham coil reproducing the same clicking sound and tactile sensation than the active rTMS will be used
Active or Sham rTMS over the Parietal cortex (Aim1b)
excitatory rTMS applied over the parietal cortex (fMRI-guided). Active and Sham rTMS will be tested in a within subject design
rTMS
excitatory 5Hz rTMS will be used
Sham rTMS
an electrical sham coil reproducing the same clicking sound and tactile sensation than the active rTMS will be used
Active or Sham rTMS over the DLPFC and the Parietal cortex (Aim1c)
excitatory rTMS applied over the DLPFC and the parietal cortex (fMRI-guided). Active and Sham rTMS will be tested in a within subject design
rTMS
excitatory 5Hz rTMS will be used
Sham rTMS
an electrical sham coil reproducing the same clicking sound and tactile sensation than the active rTMS will be used
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
rTMS
excitatory 5Hz rTMS will be used
Sham rTMS
an electrical sham coil reproducing the same clicking sound and tactile sensation than the active rTMS will be used
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Use of effective method of birth control for women of childbearing capacity.
* Willing to provide informed consent.
Exclusion Criteria
* Current serious medical illness.
* History of seizure, epilepsy, stroke, brain surgery, head injury, cranial metal implants, known structural brain lesion, devices that may be affected by rTMS or MRI (pacemaker, medication pump, cochlear implant, implanted brain stimulator)
* Inability or unwilling to give informed consent.
* Diagnosed any Axis I DSM-IV disorder (MINI, DSM-IV).
* For subjects age \> 59 years, a total scaled score \< 8 on the Dementia Rating Scale-2.
* Clinically defined neurological disorder.
* Increased risk of seizure for any reason, including prior diagnosis of increased intracranial pressure, or currently taking medication that lowers the seizure threshold.
* Claustrophobia (MRI scanner).
* Pregnancy.
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
Duke University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lawrence Appelbaum
Role: PRINCIPAL_INVESTIGATOR
Duke University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Duke University Medical Center
Durham, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Crowell CA, Davis SW, Beynel L, Deng L, Lakhlani D, Hilbig SA, Palmer H, Brito A, Peterchev AV, Luber B, Lisanby SH, Appelbaum LG, Cabeza R. Older adults benefit from more widespread brain network integration during working memory. Neuroimage. 2020 Sep;218:116959. doi: 10.1016/j.neuroimage.2020.116959. Epub 2020 May 20.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00065334
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.